These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 33268665)

  • 21. Solid lipid nanoparticles (SLN) and oil-loaded SLN studied by spectrofluorometry and Raman spectroscopy.
    Jores K; Haberland A; Wartewig S; Mäder K; Mehnert W
    Pharm Res; 2005 Nov; 22(11):1887-97. PubMed ID: 16132349
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preparation and evaluation of novel octylmethoxycinnamate-loaded solid lipid nanoparticles.
    Liu XH; Liang XZ; Fang X; Zhang WP
    Int J Cosmet Sci; 2015 Aug; 37(4):446-53. PubMed ID: 25720757
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improved anti-obesity effect of herbal active and endogenous lipids co-loaded lipid nanocarriers: Preparation, in vitro and in vivo evaluation.
    Lacatusu I; Badea N; Udeanu D; Coc L; Pop A; Cioates Negut C; Tanase C; Stan R; Meghea A
    Mater Sci Eng C Mater Biol Appl; 2019 Jun; 99():12-24. PubMed ID: 30889655
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Curcumin-Loaded Nanostructured Lipid Carrier Modified with Partially Hydrolyzed Ginsenoside.
    Selvaraj K; Yoo BK
    AAPS PharmSciTech; 2019 Jul; 20(6):252. PubMed ID: 31300965
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long chain lipid based tamoxifen NLC. Part I: preformulation studies, formulation development and physicochemical characterization.
    Shete H; Patravale V
    Int J Pharm; 2013 Sep; 454(1):573-83. PubMed ID: 23535345
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Physicochemical characterization of lycopene-loaded nanostructured lipid carrier formulations for topical administration.
    Okonogi S; Riangjanapatee P
    Int J Pharm; 2015 Jan; 478(2):726-35. PubMed ID: 25479097
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development and optimization of sulforaphane-loaded nanostructured lipid carriers by the Box-Behnken design for improved oral efficacy against cancer: in vitro, ex vivo and in vivo assessments.
    Soni K; Rizwanullah M; Kohli K
    Artif Cells Nanomed Biotechnol; 2018; 46(sup1):15-31. PubMed ID: 29183147
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sucupira Oil-Loaded Nanostructured Lipid Carriers (NLC): Lipid Screening, Factorial Design, Release Profile, and Cytotoxicity.
    Vieira R; Severino P; Nalone LA; Souto SB; Silva AM; Lucarini M; Durazzo A; Santini A; Souto EB
    Molecules; 2020 Feb; 25(3):. PubMed ID: 32041134
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preparation and characteristics of oridonin-loaded nanostructured lipid carriers as a controlled-release delivery system.
    Dai W; Zhang D; Duan C; Jia L; Wang Y; Feng F; Zhang Q
    J Microencapsul; 2010 May; 27(3):234-41. PubMed ID: 20113167
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Systematic implementation of quality-by-design (QbD) to develop NSAID-loaded nanostructured lipid carriers for ocular application: preformulation screening studies and statistical hybrid-design for optimization of variables.
    Rathod VR; Shah DA; Dave RH
    Drug Dev Ind Pharm; 2020 Mar; 46(3):443-455. PubMed ID: 32037896
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optimizing flurbiprofen-loaded NLC by central composite factorial design for ocular delivery.
    Gonzalez-Mira E; Egea MA; Souto EB; Calpena AC; García ML
    Nanotechnology; 2011 Jan; 22(4):045101. PubMed ID: 21169662
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development and evaluation of puerarin-loaded controlled release nanostructured lipid carries by central composite design.
    Ye Q; Li J; Li T; Ruan J; Wang H; Wang F; Zhang X
    Drug Dev Ind Pharm; 2021 Jan; 47(1):113-125. PubMed ID: 33289579
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Carbamazepine-loaded solid lipid nanoparticles and nanostructured lipid carriers: Physicochemical characterization and in vitro/in vivo evaluation.
    Scioli Montoto S; Sbaraglini ML; Talevi A; Couyoupetrou M; Di Ianni M; Pesce GO; Alvarez VA; Bruno-Blanch LE; Castro GR; Ruiz ME; Islan GA
    Colloids Surf B Biointerfaces; 2018 Jul; 167():73-81. PubMed ID: 29627680
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modified NLC-loaded coumarin for pharmaceutical applications: the improvement of physical stability and controlled release profile.
    Iemsam-Arng J; Ketchart O; Rattana-Amron T; Wutikhun T; Tapaneeyakorn S
    Pharm Dev Technol; 2016 Dec; 21(8):1015-1022. PubMed ID: 26401882
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Near-infrared mediated quantum dots and paclitaxel co-loaded nanostructured lipid carriers for cancer theragnostic.
    Olerile LD; Liu Y; Zhang B; Wang T; Mu S; Zhang J; Selotlegeng L; Zhang N
    Colloids Surf B Biointerfaces; 2017 Feb; 150():121-130. PubMed ID: 27907859
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Propolis wax nanostructured lipid carrier for delivery of β sitosterol: Effect of formulation variables on physicochemical properties.
    Soleimanian Y; Goli SAH; Varshosaz J; Maestrelli F
    Food Chem; 2018 Sep; 260():97-105. PubMed ID: 29699688
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Solidification of Nanostructured Lipid Carriers Loaded Testosterone Undecanoate: In Vivo and In Vitro Study.
    Hua Y; Li W; Cheng Z; Zhao Z; Yin X; Li Y; Sun J; Gao J; Zhang H; Zheng A
    Drug Res (Stuttg); 2018 Aug; 68(8):457-464. PubMed ID: 29589341
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nanostructured lipid carriers (NLC) for parenteral delivery of an anticancer drug.
    Chinsriwongkul A; Chareanputtakhun P; Ngawhirunpat T; Rojanarata T; Sila-on W; Ruktanonchai U; Opanasopit P
    AAPS PharmSciTech; 2012 Mar; 13(1):150-8. PubMed ID: 22167418
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design, characterization and in vivo evaluation of nanostructured lipid carriers (NLC) as a new drug delivery system for hydrochlorothiazide oral administration in pediatric therapy.
    Cirri M; Maestrini L; Maestrelli F; Mennini N; Mura P; Ghelardini C; Di Cesare Mannelli L
    Drug Deliv; 2018 Nov; 25(1):1910-1921. PubMed ID: 30451015
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of indomethacin-loaded lipid nanoparticles by differential scanning calorimetry.
    Castelli F; Puglia C; Sarpietro MG; Rizza L; Bonina F
    Int J Pharm; 2005 Nov; 304(1-2):231-8. PubMed ID: 16188405
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.